TY - JOUR
T1 - One-Pot Synthesis of Pyrimido[4,5-d]pyrimidine Derivatives and Investigation of Their Antibacterial, Antioxidant, DNA-Binding and Voltammetric Characteristics
AU - Santosh, Rangappa
AU - Paul, Priyodip
AU - KS, Mukunthan
AU - Raril, Chenthattil
AU - Krishna, Panchangam M.
AU - Manjunatha, Jamballi G.
AU - Nagaraja, Gundibasappa K.
N1 - Publisher Copyright:
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2019/1/23
Y1 - 2019/1/23
N2 - Dihydropyrimidinones (DHPMs), 4 a-f and 6 a-f is reported and were characterized by 1H-NMR, 13C-NMR, FT-IR and LC–MS. The synthesized compounds were evaluated for their antibacterial activity against Staphylococcus aureus (S.aureus), Bacillus subtilis (B. subtilis), Salmonella typhi (S. typhi) and Pseudomonas aeruginosa (P. aeruginosa). Among the test samples compounds, 5-(4-hydroxy-3-methoxyphenyl)-7-imino-1,3,5,6,8-pentahydropyrimido[4,5-d]pyrimidine-2,4-dione (6 c) and 5-(4-hydroxy-3,5-dimethoxyphenyl)-1,3-N,N-dimethyl-7-thioxo-5,6,8-trihydropyrimido[4,5-d]pyrimidine-2,4-dione (4 d) were more potent against S. aureus and B. subtilis. Whereas 5-(4-hydroxy-3-methoxyphenyl)-1,3-N,N-dimethyl-5,6,8-trihydropyrimido[4,5-d]pyrimidine-2,4,7-trione (6 e) and 5-(4-hydroxy-3,5-dimethoxyphenyl)-1,3-N,N-dimethyl-5,6,8-trihydropyrimido[4,5-d]pyrimidine-2,4,7-trione (4 e) showed good inhibition against S. typhi and P. aeruginosa which were well supported by computational interaction and DNA binding studies. Compound 5-(4-hydroxy-3,5-dimethoxyphenyl)-7-imino-1,3,5,6,8-pentahydropyrimido[4,5-d]pyrimidine-2,4,7-trione (4 c) exhibited potent scavenging activity with IC50 of 8.30 mg/ml. Furthermore, Cyclic Voltammetric analysis disclosed that 5-(4-hydroxy-3,5-dimethoxyphenyl)-7-thioxo-1,3,5,6,8-pentahydropyrimido[4,5-d]pyrimidine-2,4-dione (4 a), 5-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,5,6,8-pentahydropyrimido[4,5-d]pyrimidine-2,4,7-trione (4 b), 4 c, 6 d, 6 e, and 6 f showed redox behavior.
AB - Dihydropyrimidinones (DHPMs), 4 a-f and 6 a-f is reported and were characterized by 1H-NMR, 13C-NMR, FT-IR and LC–MS. The synthesized compounds were evaluated for their antibacterial activity against Staphylococcus aureus (S.aureus), Bacillus subtilis (B. subtilis), Salmonella typhi (S. typhi) and Pseudomonas aeruginosa (P. aeruginosa). Among the test samples compounds, 5-(4-hydroxy-3-methoxyphenyl)-7-imino-1,3,5,6,8-pentahydropyrimido[4,5-d]pyrimidine-2,4-dione (6 c) and 5-(4-hydroxy-3,5-dimethoxyphenyl)-1,3-N,N-dimethyl-7-thioxo-5,6,8-trihydropyrimido[4,5-d]pyrimidine-2,4-dione (4 d) were more potent against S. aureus and B. subtilis. Whereas 5-(4-hydroxy-3-methoxyphenyl)-1,3-N,N-dimethyl-5,6,8-trihydropyrimido[4,5-d]pyrimidine-2,4,7-trione (6 e) and 5-(4-hydroxy-3,5-dimethoxyphenyl)-1,3-N,N-dimethyl-5,6,8-trihydropyrimido[4,5-d]pyrimidine-2,4,7-trione (4 e) showed good inhibition against S. typhi and P. aeruginosa which were well supported by computational interaction and DNA binding studies. Compound 5-(4-hydroxy-3,5-dimethoxyphenyl)-7-imino-1,3,5,6,8-pentahydropyrimido[4,5-d]pyrimidine-2,4,7-trione (4 c) exhibited potent scavenging activity with IC50 of 8.30 mg/ml. Furthermore, Cyclic Voltammetric analysis disclosed that 5-(4-hydroxy-3,5-dimethoxyphenyl)-7-thioxo-1,3,5,6,8-pentahydropyrimido[4,5-d]pyrimidine-2,4-dione (4 a), 5-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,5,6,8-pentahydropyrimido[4,5-d]pyrimidine-2,4,7-trione (4 b), 4 c, 6 d, 6 e, and 6 f showed redox behavior.
UR - http://www.scopus.com/inward/record.url?scp=85060446547&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060446547&partnerID=8YFLogxK
U2 - 10.1002/slct.201803416
DO - 10.1002/slct.201803416
M3 - Article
AN - SCOPUS:85060446547
SN - 2365-6549
VL - 4
SP - 990
EP - 996
JO - ChemistrySelect
JF - ChemistrySelect
IS - 3
ER -